CA2543132A1 - Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur - Google Patents

Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur Download PDF

Info

Publication number
CA2543132A1
CA2543132A1 CA002543132A CA2543132A CA2543132A1 CA 2543132 A1 CA2543132 A1 CA 2543132A1 CA 002543132 A CA002543132 A CA 002543132A CA 2543132 A CA2543132 A CA 2543132A CA 2543132 A1 CA2543132 A1 CA 2543132A1
Authority
CA
Canada
Prior art keywords
carbon atoms
pain
alkyl
substituted
cytokine inhibitory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002543132A
Other languages
English (en)
Inventor
Jerome B. Zeldis
Herbert Faleck
Donald C. Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corporation
Jerome B. Zeldis
Herbert Faleck
Donald C. Manning
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/693,722 external-priority patent/US20040087558A1/en
Application filed by Celgene Corporation, Jerome B. Zeldis, Herbert Faleck, Donald C. Manning filed Critical Celgene Corporation
Priority claimed from PCT/US2004/012722 external-priority patent/WO2005043971A2/fr
Publication of CA2543132A1 publication Critical patent/CA2543132A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
CA002543132A 2003-10-23 2004-04-23 Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur Abandoned CA2543132A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/693,722 US20040087558A1 (en) 2002-10-24 2003-10-23 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
US10/693,722 2003-10-23
PCT/US2004/012722 WO2005043971A2 (fr) 2003-10-23 2004-04-23 Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur

Publications (1)

Publication Number Publication Date
CA2543132A1 true CA2543132A1 (fr) 2005-05-19

Family

ID=36636802

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002543132A Abandoned CA2543132A1 (fr) 2003-10-23 2004-04-23 Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur

Country Status (2)

Country Link
JP (1) JP2007524656A (fr)
CA (1) CA2543132A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110200978A (zh) * 2016-04-22 2019-09-06 维京治疗股份有限公司 甲状腺β-激动剂的应用
CN111743871A (zh) * 2020-07-14 2020-10-09 天方药业有限公司 盐酸酚苄明片剂及其制备方法
US11951114B2 (en) 2016-04-22 2024-04-09 Viking Therapeutics, Inc. Use of thyroid beta-agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
CZ299873B6 (cs) * 1997-07-31 2008-12-17 Celgene Corporation Derivát hydroxamové kyseliny a farmaceutický prostredek s jeho obsahem
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
US6667316B1 (en) * 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
SE0101256D0 (sv) * 2001-04-06 2001-04-06 A & Science Invest Ab Treatment of low back pain
US6962940B2 (en) * 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110200978A (zh) * 2016-04-22 2019-09-06 维京治疗股份有限公司 甲状腺β-激动剂的应用
CN110200978B (zh) * 2016-04-22 2023-10-31 维京治疗股份有限公司 甲状腺β-激动剂的应用
US11951114B2 (en) 2016-04-22 2024-04-09 Viking Therapeutics, Inc. Use of thyroid beta-agonists
CN111743871A (zh) * 2020-07-14 2020-10-09 天方药业有限公司 盐酸酚苄明片剂及其制备方法

Also Published As

Publication number Publication date
JP2007524656A (ja) 2007-08-30

Similar Documents

Publication Publication Date Title
ZA200603461B (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
AU2003284979B2 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
MX2007006992A (es) Composiciones que comprenden moduladores pde4 y su uso para el tratamiento o prevencion de la inflamacion de las vias aereas.
EP1553951A2 (fr) Compositions contenant un inhibiteur de jnk destinees a traiter, prevenir, gerer et/ou modifier la douleur, et leurs methodes d'utilisation
US20060106085A1 (en) Methods and compositions using PDE4 modulators for treatment and management of central nervous system injury
AU2003286663B2 (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
US20070161696A1 (en) Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
US7612096B2 (en) Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
CA2543132A1 (fr) Procedes d'utilisations et compositions comprenant des medicaments selectifs inhibiteurs de la cytokine utilises dans le traitement, la modification et la gestion de la douleur

Legal Events

Date Code Title Description
FZDE Discontinued